BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND TRIM27, DASS-46L4_6, RFP, 5987, ENSG00000234495, RNF76
50225 results:

  • 1. Efficacy and Safety of Radiation Segmentectomy with
    Sarwar A; Malik MS; Vo NH; Tsai LL; Tahir MM; Curry MP; Catana AM; Bullock AJ; Parker JA; Eckhoff DE; Nasser IA; Weinstein JL; Ahmed M
    Radiology; 2024 May; 311(2):e231386. PubMed ID: 38713023
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The pattern of tumor progression on first-line immune checkpoint inhibitor-based systemic therapy for Chinese advanced hepatocellular carcinoma -CLEAP 004 study.
    Yang CX; Pan YX; Ye F; Zhu XD; Xue J; Li X; Yuan ZG; Zhang L; Xu L; Chen YJ; Wang NY; Sun HC; Liu XF;
    Front Immunol; 2024; 15():1310239. PubMed ID: 38711515
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Efficacy and safety of hepatic arterial infusion chemotherapy combined with lenvatinib and PD-1 inhibitors for advanced hepatocellular carcinoma with macrovascular invasion.
    Zhang Y; Zhang H; Xu H; Wang Y; Feng L; Yi F
    World J Surg Oncol; 2024 May; 22(1):122. PubMed ID: 38711095
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A case study of a liver transplant-treated patient with glycogen storage disease type Ia presenting with multiple inflammatory hepatic adenomas: an analysis of clinicopathologic and genetic data.
    Wang A; Wu J; Yuan X; Liu J; Lu C
    BMC Med Genomics; 2024 May; 17(1):124. PubMed ID: 38711024
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Safety, efficacy, and survival of different transarterial chemoembolization techniques in the management of unresectable hepatocellular carcinoma: a comparative single-center analysis.
    Schindler P; Kaldewey D; Rennebaum F; Trebicka J; Pascher A; Wildgruber M; Köhler M; Masthoff M
    J Cancer Res Clin Oncol; 2024 May; 150(5):235. PubMed ID: 38710956
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Long-term survival after hepatic resection for colorectal liver metastases: a single-center study in Iran.
    Pourfaraji SM; Moghadam MN; Moradi AM; Shirmard FO; Mohammadzadeh N; Jafarian A
    BMC Surg; 2024 May; 24(1):131. PubMed ID: 38702645
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Prevalence and risk of nonalcoholic fatty liver disease among adult psoriatic patients: A systematic review, meta-analysis, and trial sequential analysis.
    Hu J; Shao Y; Gui C; Xiao Y; Li L; Li Z
    Medicine (Baltimore); 2024 May; 103(18):e38007. PubMed ID: 38701269
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Efficacy and safety of transarterial chemoembolization combined with targeted therapy and immunotherapy versus with targeted monotherapy in unresectable hepatocellular carcinoma: A systematic review and meta-analysis.
    Feng J; Zhao Y; Zhai L; Zhou J
    Medicine (Baltimore); 2024 May; 103(18):e38037. PubMed ID: 38701263
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The clinical significance of sarcopenia in patients with hepatocellular carcinoma treated with lenvatinib and PD-1 inhibitors.
    Sun W; Yin X; Liu X; Wei J; Yu M; Li W; Ding X; Chen J
    Front Immunol; 2024; 15():1380477. PubMed ID: 38698848
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Evaluation of TikTok videos on acute pancreatitis: content quality and reliability analysis.
    Mao T; Zhao X; Jiang K; Yang J; Xie Q; Fu J; Du B; Lei Z; Gao F
    BMC Public Health; 2024 May; 24(1):1216. PubMed ID: 38698404
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Predictive factors of 90-day mortality after curative hepatic resection for hepatocellular carcinoma: a western single-center observational study.
    Vaghiri S; Lehwald-Tywuschik N; Prassas D; Safi SA; Kalmuk S; Knoefel WT; Dizdar L; Alexander A
    Langenbecks Arch Surg; 2024 May; 409(1):149. PubMed ID: 38698255
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Circulating fatty acids and risk of hepatocellular carcinoma and chronic liver disease mortality in the UK Biobank.
    Liu Z; Huang H; Xie J; Xu Y; Xu C
    Nat Commun; 2024 May; 15(1):3707. PubMed ID: 38697980
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Tebentafusp in the treatment of metastatic uveal melanoma - the first patient treated in the Czech Republic.
    Klabusay M; Bábková B
    Klin Onkol; 2024; 38(2):134-138. PubMed ID: 38697822
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Bioaccumulation and health risk assessment of trace elements in Tilapia (Oreochromis mossambicus) from selected inland water bodies.
    Balamanikandan V; Shalini R; Arisekar U; Shakila RJ; Padmavathy P; Sivaraman B; Devanesan S; Sundhar S; AlSalhi MS; Mythili R; Kim W
    Environ Geochem Health; 2024 May; 46(6):187. PubMed ID: 38696018
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Bortezomib in previously treated phosphatase and tension homology-deficient patients with advanced intrahepatic cholangiocarcinoma: An open-label, prospective and single-centre phase II trial.
    Zeng TM; Jiang TY; Yang G; Cheng Z; Lou C; Wei W; Tao CJ; Hu S; Wang H; Cui XW; Tan YX; Dong LW; Wang HY; Yuan ZG
    Clin Transl Med; 2024 May; 14(5):e1675. PubMed ID: 38689424
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. High prevalence of diabetes among young First Nations Peoples with metabolic dysfunction-associated steatotic liver disease: a population-based study in Australia.
    Valery PC; Roche S; Brown C; O'Beirne J; Hartel G; Leggett B; Skoien R; Powell EE
    Int J Equity Health; 2024 Apr; 23(1):84. PubMed ID: 38689295
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Diffusion probabilistic versus generative adversarial models to reduce contrast agent dose in breast MRI.
    Müller-Franzes G; Huck L; Bode M; Nebelung S; Kuhl C; Truhn D; Lemainque T
    Eur Radiol Exp; 2024 May; 8(1):53. PubMed ID: 38689178
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. A Comparative Analysis of Implant-sparing Plan
    Onal C; Bozca R; Dolek Y; Elmali A; Guler OC
    In Vivo; 2024; 38(3):1412-1420. PubMed ID: 38688603
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Efficacy of microwave ablation with parallel acupuncture guided by ultrasound in treating single hepatocellular carcinoma in high-risk areas: A retrospective analysis of 155 patients.
    Liu S; Zhou P; Shen Q; Qian G
    J Cancer Res Ther; 2024 Apr; 20(2):547-554. PubMed ID: 38687924
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Usefulness of atezolizumab plus bevacizumab as second-line therapy for patients with unresectable hepatocellular carcinoma.
    Yamaba S; Imai Y; Sugawara K; Uchida Y; Fuchigami A; Uchiya H; Nakayama N; Mochida S
    PLoS One; 2024; 19(4):e0298770. PubMed ID: 38687817
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2512.